NCT02849184View on ClinicalTrials.gov

To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 17, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

March 31, 2018

Conditions
HypertensionInsomnia
Interventions
DRUG

suvorexant

Suvorexant (20mg for 64 years or younger; 15mg for 65 years or older) once daily before bedtime.

OTHER

Placebo

Placebo once daily before bedtime.

Trial Locations (3)

Unknown

Takahira Internal Medicine Clinic, Fukuoka

Yamasaki family clinic, Hyōgo

Yagi hospital, Tokyo

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Satt Co.,Ltd

UNKNOWN

lead

Jichi Medical University

OTHER

NCT02849184 - To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia | Biotech Hunter | Biotech Hunter